Article
Life Sciences Outlook 2026 - Pharma Regulatory And Compliance
The EU continues its ambitious reform agenda for life sciences regulation, with landmark agreements on pharmaceutical legislation and biotech innovation frameworks. Ireland's Council Presidency is set to drive progress on critical medicines legislation and medical device reforms, while new investment initiatives aim to mobilize billions into Europe's biotech sector.
Arthur Cox